Our projects

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).

TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...

Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...

Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...

Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.

Antibiotic-based combination therapy for severe malaria and bacterial bloodstream infectionsThe FACT project is developing an innovative treatment that targets both severe malaria and...

Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...

Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.

Automating parasite egg detectionThe DIDIDI project is developing automated systems and AI tools to provide a more rapid assessment of parasitic worm burdens.

Protecting contacts of Bundibugyo patientsThe EBO-PEP 2026 project is assessing whether an antiviral can prevent disease in individuals who have had close contact with patients with the...

Closing the diagnostic gap for paediatric tuberculosisThe ACT4KIDS-TB project is assessing whether combining different data sources can enable a clinic-decision-making app that supports...

Extending malaria treatment options for young childrenThe ASAQ-PAC project is developing a child-friendly version of a key antimalarial combination to enable malaria control programmes to...

Protecting the potency of a key tuberculosis drugThe TASP project is evaluating new approaches to extend the lifespan of the critical tuberculosis drug, bedaquiline, by improving detection...

Progressing a multifunctional antimalarialThe RAMP project is advancing the development of a novel antimalarial drug with the potential to both treat the disease and block the transmission...

Treating epilepsy caused by parasite infection  The NeuroSolve project is evaluating a new treatment for patients who develop epileptic seizures when tapeworm larvae become lodged in their...